Displaying 1–25 of 52 results for IBM

Sort By Relevance Sort By Date
1 2 3

IBM pulling the plug on Watson AI sales for drug discovery

(News)

IBM Watson will no longer sell an artificial intelligence tool the company developed to aid with early drug development.

Novartis Partners with IBM Watson on Breast Cancer Initiative

(News)

The partnership aims to explore methods of using patient data and advanced analysis to glean insights on likely breast cancer treatment outcomes.

Industrial Internet of Things Primer: Bridge the Gap Between OT and IT

(Article)

To realize the promise of the Internet of Things, operational technology systems and information technology systems must converge, allowing connection and communication.

Pharma’s Search for Operational Truth

(Article)

Integration of control and business information technologies are opening new windows of enterprise transparency

Teva is First to Partner with IBM on New Health Cloud

(News)

Teva Pharmaceutical and IBM Watson Health have announced a strategic partnership whereby Teva will be the first global pharmaceutical company to tap the power of the Watson Health Cloud.

How to Integrate Multigenerational Automation Systems

(Article)

Improving legacy automation systems can present a variety of challenges

Seven Steps for Serialization-Ready Systems

(Article)

If your equipment is not ready, it’s time to get it ready

The Scientific Data Crowdsourcing Challenge

(Article)

The sbv IMPROVER project is funded by Philip Morris International and is a collaborative effort between scientists from PMI’s Research and Development department, IBM’s Thomas J. Watson Research Center and, most notably, the entire scientific community.

The Way of Collaboration

(Article)

Want a healthier pharma supply chain? Pave the way with collaboration

Coming of Age

(Article)

It’s been 10 years since the FDA released Pharmaceutical GMPs for the 21st Century, but it’s likely the next 10 that will shape the industry for decades after

Potato Chips, Soap Flakes, Biopharm (and Pharma)

(Article)

Consultant Robert Dream shares thoughts on evolving industries

From Go-Karts to Formula 1: Distinguishing True Digital Signatures

(Article)

Digital signatures have grown in sophistication and import, becoming a staple of serious and compliant drug manufacturers, explains SAFE-Biopharma's Mollie Shields-Uehling.

Study Reveals 63% of Pharmaceutical Companies Rely on Third-Party Outsourcing

(News)

New IDC Health Insights Study Reveals 63% of Pharmaceutical Companies Rely on Third-Party Outsourcing Firms to Enhance Their Manufacturing and Supply Chain Strategies

How Lean is Pharma?: A 10-Year Progress Report

(Article)

So much is to be gained, yet it is hard to tell whether any drug manufacturer has truly made progress over the last decade.

What Your ICH Q8 Design Space Needs: A Multivariate Predictive Distribution

(Article)

Multivariate predictive distribution quantifies the level of QA in a design space. "Parametric bootstrapping" can help simplify early analysis and complement Bayesian methods.

The Path to Epedigree: Manufacturers Chart Their Course

(Article)

During a legislative lull, drug manufacturers muster up momentum to implement electronic pedigree programs.

PharmaView: Lilly’s Head Is in the Clouds: Virtualize Computing

(Article)

By virtualizing its computing, Lilly can do more, with more people involved.

FDA’s Process Validation Guidance Calls for Technology Solutions

(Article)

The draft guidance is a win-win-win: good for FDA, consumers, and manufacturers.

Best Practices for Cancer APIs

(Article)

Ash Stevens shares information gained from years in the business, and how it will make a new CMC alliance work with various partners.

Imperfect Harmony: Life Sciences Companies Must Partner to Thrive

(Whitepaper)

A just-released IBM study suggests that if life sciences companies do not collaborate, they risk delays in production. The survey, "An Imperfect Harmony: Alliances within the Life Sciences Industry," says that while the number of partnerships between larger and smaller life-sciences companies has...

Sidney Taurel to Retire as Lilly CEO

(Article)

Eli Lilly and Company has announced that Sidney Taurel, chief executive officer and chairman of the board, will retire as CEO effective March 31, 2008. Taurel will remain chairman of the company's board of directors until December 31, 2008, at which time he will retire from the board and from the...

Sort By Relevance Sort By Date
1 2 3